The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples

被引:4
|
作者
Peng, Hongwei [1 ]
Pan, Ming [2 ]
Zhou, Zongning [1 ]
Chen, Congbo [3 ]
Xing, Xing [4 ]
Cheng, Shaoping [4 ]
Zhang, Shanshan [1 ]
Zheng, Hang [5 ]
Qian, Kaiyu [1 ,5 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Hubei Key Lab Urol Dis,Dept Biol Repositories, Wuhan, Peoples R China
[2] Hubei Univ Med, Taihe Hosp, Taihe Skills Training Ctr, Shiyan, Hubei, Peoples R China
[3] Hubei Univ Med, Taihe Hosp, Dept Urol, Shiyan, Hubei, Peoples R China
[4] Yangtze Univ, Affiliated Hosp 1, Dept Urol, Jingzhou, Hubei, Peoples R China
[5] Wuhan Univ, Zhongnan Hosp, Dept Urol, Lab Precis Med, Wuhan, Peoples R China
关键词
cell-free DNA (cfDNA); preanalytical variables; standardization; blood; urine; CIRCULATING TUMOR DNA; FREE PLASMA DNA; LIQUID BIOPSY; COLLECTION TUBES; COMMERCIAL KITS; NUCLEIC-ACIDS; CANCER DIAGNOSTICS; LUNG-CANCER; DIGITAL PCR; SERUM;
D O I
10.3389/fcell.2024.1385041
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cell-free DNA (cfDNA), a burgeoning class of molecular biomarkers, has been extensively studied across a variety of biomedical fields. As a key component of liquid biopsy, cfDNA testing is gaining prominence in disease detection and management due to the convenience of sample collection and the abundant wealth of genetic information it provides. However, the broader clinical application of cfDNA is currently impeded by a lack of standardization in the preanalytical procedures for cfDNA analysis. A number of fundamental challenges, including the selection of appropriate preanalytical procedures, prevention of short cfDNA fragment loss, and the validation of various cfDNA measurement methods, remain unaddressed. These existing hurdles lead to difficulties in comparing results and ensuring repeatability, thereby undermining the reliability of cfDNA analysis in clinical settings. This review discusses the crucial preanalytical factors that influence cfDNA analysis outcomes, including sample collection, transportation, temporary storage, processing, extraction, quality control, and long-term storage. The review provides clarification on achievable consensus and offers an analysis of the current issues with the goal of standardizing preanalytical procedures for cfDNA analysis.
引用
收藏
页数:20
相关论文
共 50 条
  • [41] Analysis of KRAS mutation allele in circulating cell-free DNA derived from urine in colorectal cancer patients
    Ohta, Ryo
    Yamada, Takeshi
    Sonoda, Hiromichi
    Matsuda, Akihisa
    Shinji, Seiichi
    Takahashi, Goro
    Iwai, Takuma
    Takeda, Kohki
    Ueda, Koji
    Kuriyama, Sho
    Miyasaka, Toshimitsu
    CANCER SCIENCE, 2021, 112 : 434 - 434
  • [42] Maternal urine for prenatal diagnosis - an analysis of cell-free fetal DNA in maternal urine and plasma in the third trimester
    Majer, Sandra
    Bauer, Margit
    Magnet, Eva
    Strele, Andrea
    Giegerl, Elisabeth
    Eder, Martina
    Lang, Uwe
    Pertl, Barbara
    PRENATAL DIAGNOSIS, 2007, 27 (13) : 1219 - 1223
  • [43] Analysis of DNA Methylation in Gliomas: Assessment of Preanalytical Variables
    Bomsztyk, Karol
    Mar, Daniel
    Denisenko, Oleg
    Powell, Suzanne
    Vishnoi, Monika
    Yin, Zheng
    Delegard, Jennifer
    Hadley, Caroline
    Tandon, Nitin
    Patel, Akash J.
    Patel, Anoop P.
    Ellenbogen, Richard G.
    Ramakrishna, Rohan
    Rostomily, Robert C.
    LABORATORY INVESTIGATION, 2024, 104 (12)
  • [44] Analysis of Cell-Free DNA in Maternal Blood in Screening for Aneuploidies: Meta-Analysis
    Gil, M. M.
    Akolekar, R.
    Quezada, M. S.
    Bregant, B.
    Nicolaides, K. H.
    FETAL DIAGNOSIS AND THERAPY, 2014, 35 (03) : 156 - 173
  • [45] Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory Breast Cancer
    Winn, Jennifer S.
    Hasse, Zachary
    Slifker, Michael
    Pei, Jianming
    Arisi-Fernandez, Sebastian M.
    Talarchek, Jacqueline N.
    Obeid, Elias
    Baldwin, Donald A.
    Gong, Yulan
    Ross, Eric
    Cristofanilli, Massimo
    Alpaugh, R. Katherine
    Fernandez, Sandra, V
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
  • [46] Quantification of human papillomavirus cell-free DNA from low-volume blood plasma samples by digital PCR
    Rosing, Fabian
    Meier, Matthias
    Schroeder, Lea
    Laban, Simon
    Hoffmann, Thomas
    Kaufmann, Andreas
    Siefer, Oliver
    Wuerdemann, Nora
    Klussmann, Jens Peter
    Rieckmann, Thorsten
    Alt, Yvonne
    Faden, Daniel L.
    Waterboer, Tim
    Hoefler, Daniela
    MICROBIOLOGY SPECTRUM, 2024, 12 (07) : e0002424
  • [47] Circulating cell free DNA: Preanalytical considerations
    El Messaoudi, Safia
    Rolet, Fanny
    Mouliere, Florent
    Thierry, Alain R.
    CLINICA CHIMICA ACTA, 2013, 424 : 222 - 230
  • [48] Comparison of cell-free DNA blood collection tubes
    Browne, Cecille D.
    Mattmann, Margrith E.
    Wycoco, Marc J.
    Chen, Sheila N.
    Ravichandran, Rajeswari
    Desharnais, Joel
    Varela, Laura J.
    Browne, Jonathan D.
    Liberal, Vasco
    Lee, Florence
    CANCER RESEARCH, 2017, 77
  • [49] Cell-free DNA as a Clinical Indicator in Maternal Blood
    Al-Omary, Hanan L.
    Alawad, Zainab M.
    Husseini, Buraq
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2019, 23 (03) : 174 - 180
  • [50] Comparison of urine cell-free DNA with blood-based screening for detection of bladder cancer.
    Stewart, Tyler F.
    Shenoy, Archana
    Stuart, Sarah M.
    McClintock, Kelly
    Bagaria, Siddhartha
    So, Tiffany
    Bagrodia, Aditya
    Salmasi, Amirali
    Kader, A. Karim
    Monga, Manoj
    Buckley, Jill
    Shabaik, Ahmed
    Larson, Matthew H.
    McKay, Rana R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41